Navigation Links
Mayo Clinic finds withdrawing ventricular assist device support ethical
Date:8/2/2010

ROCHESTER, Minn. - Patients have the right to refuse or request the withdrawal of any unwanted treatment. In an article published in the online issue of Mayo Clinic Proceedings, investigators explore the legal and ethical permissibility of carrying out such a request specific to a ventricular assist device (VAD).

The left-VAD (LVAD) is a new technology that provides circulatory support for patients with severe heart failure who are awaiting a heart transplant. This technology also can serve as a long-term treatment option for patients who are not candidates for heart transplant, but still need circulatory support, also known as "destination therapy."

Notably, VAD technology is continuously improving. "A recent trial demonstrated significantly greater two-year survival among patients with severe heart failure treated with continuous-flow LVADs than among patients treated with older pulsatile-flow devices (58 percent versus 24 percent)," says Paul Mueller, M.D., lead investigator, Mayo Clinic Department of General Internal Medicine. At Mayo Clinic the two-year survival rate for patients treated with LVAD is 74 percent. Therefore, the VAD is a long-term treatment for patients with severe heart failure.

Nevertheless, some patients treated with VADs experience complications (e.g., stroke) related to their treatment or their underlying disease and request withdrawal of VAD support.

Dr. Mueller and colleagues describe 14 patients who requested (or their surrogates requested) withdrawal of LVAD support and these requests were carried out by their physicians. Dr. Mueller and colleagues then describe the ethical and legal permissibility of carrying out such requests.

"If the patient (or their surrogate) concludes that VAD support is more burdensome than beneficial, they may request withdrawal of VAD support (that is, that the device be turned off)," says Dr. Mueller. "Assuming the patient (or surrogate) is infor
'/>"/>

Contact: Rebecca Finseth
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Clinical trials can be improved by managing the learning curve
2. Mayo Clinic Center for Innovation to sponsor a collaborative symposium on innovations in health care experience and delivery
3. Sickle cell treatment developed at LA BioMed enters Phase 3 clinical trial
4. UC San Diego receives major clinical and translational science award
5. Hopkins faculty lead development of report to FDA on ethical, scientific issues related to post-market clinical trials
6. Mayo Clinic Proceedings: Sexual abuse survivors have increased of psychiatric disorders
7. Mayo Clinic study finds apathy and depression predict progression from mild cognitive impairment
8. Pediatric clinical studies appear prone to bias, Hopkins review shows
9. St. Elizabeth Dental Clinic Named one of the Best in the Nation
10. Electronic health records prime clinicians to provide progressive care to older adults
11. CELLING Treatment Centers New Clinic Revolutionizes Spinal Care with Adult Stem Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... -- In books and movies, plots involving older men chasing ... research suggests that the stereotype may be grounded in fact. ... more than 12,000 people from Finland. The researchers, led ... that women typically preferred men who were the same age ... On the other hand, men tended to have a ...
(Date:9/30/2014)... Red Bank, New Jersey (PRWEB) September 30, 2014 ... Jersey’s largest not-for-profit visiting nurse association—is pleased to announce ... officer, was honored with a NJBIZ “40 Under ... 40 of New Jersey’s most accomplished young businessmen and ... and who share a commitment to business growth, professional ...
(Date:9/30/2014)... 2014 AxoGen, Inc. (NASDAQ: AXGN), ... peripheral nerve repair market, announced the presentation of clinical ... Society for Surgery of the Hand (ASSH) 2014 Annual ... , The ASSH Best Paper Award was ... Nerve Allografts for Large Gap Nerve Discontinuities: Outcomes From ...
(Date:9/30/2014)... SOLON, OH (PRWEB) September 30, 2014 ... wiper blades sporting the iconic pink ribbon in support ... October, a popular month for businesses and non-profits to ... this worthwhile cause. , AutoTex PINK is a woman-owned ... windshield wipers. They are committed to partnering with ...
(Date:9/30/2014)... September 30, 2014 ... , From:        Hope For The ... abarnwell(at)hopeforthewarriors(dot)org , Event:        Got ... , Date:        Thursday, October 2, ... and Navy Club, 901 ...
Breaking Medicine News(10 mins):Health News:When It Comes to Sex Partners, Men Prefer Younger Women: Study 2Health News:Visiting Nurse Association Health Group’s Dr. Steven Landers Honored with NJ BIZ “40 Under 40” Award 2Health News:Visiting Nurse Association Health Group’s Dr. Steven Landers Honored with NJ BIZ “40 Under 40” Award 3Health News:AxoGen, Inc. Announces Presentation of Clinical Data for Avance® Nerve Graft at American Society for Surgery of the Hand 2014 Annual Meeting 2Health News:AxoGen, Inc. Announces Presentation of Clinical Data for Avance® Nerve Graft at American Society for Surgery of the Hand 2014 Annual Meeting 3Health News:AxoGen, Inc. Announces Presentation of Clinical Data for Avance® Nerve Graft at American Society for Surgery of the Hand 2014 Annual Meeting 4Health News:AxoGen, Inc. Announces Presentation of Clinical Data for Avance® Nerve Graft at American Society for Surgery of the Hand 2014 Annual Meeting 5Health News:Change Your Blades … Change A Life! AutoTex PINK Wiper Blades Are Helping Wipe Out Breast Cancer 2Health News:Change Your Blades … Change A Life! AutoTex PINK Wiper Blades Are Helping Wipe Out Breast Cancer 3Health News:Hope For The Warriors' Got Heart, Give Hope Celebration Media Advisory 2
... Brun, fierce mental health advocate for hurricane-traumatized children, is ... Sister Judith Brun, CSJ, who has worked tirelessly to ... still suffering hurricane-induced trauma in Louisiana, will address the ... Commencement on June 7. , , Brun,s ...
... , , HAE:TSX, ... , MONTREAL, June 3 /PRNewswire-FirstCall/ - Haemacure Corporation ... and Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI , TSX:ANP) ... Angiotech to Haemacure in a minimum amount of US$2.5 ...
... The SSI Group, Inc. (SSI) announced their success in ... Health System (DUHS) and its affiliated hospitals for a ... the primary supplier of claims management products, including but not ... functionality of posting back billing information to the host HIS ...
... A University of Toronto study provides the first direct evidence ... filters our perceptual experience suggesting that seeing the world through ... and bad moods literally change the way our visual cortex ... of T professor of psychology. "Specifically our study shows ...
... An over-the-counter prostate cancer test kit could be coming to ... a University of Central Florida chemist and M.D. Anderson Cancer ... M.D. Anderson-Orlando,s Dr. Cheryl Baker and Jimmie Colon teamed up ... wanted to develop an effective, inexpensive test to screen for ...
... new review published in the Journal of Human Nutrition ... a beneficial effect on the prevention of prostate cancer. Results ... and high in fruits and vegetables is beneficial in preventing ... K. Chapman conducted an evidence-based review of dietary recommendations in ...
Cached Medicine News:Health News:Three New Programs Confer Degrees at MSPP Graduation on June 7, 2009 2Health News:Three New Programs Confer Degrees at MSPP Graduation on June 7, 2009 3Health News:Three New Programs Confer Degrees at MSPP Graduation on June 7, 2009 4Health News:Haemacure and Angiotech Enter License, Distribution and Supply Agreements for Haemacure's All-Human Fibrin Sealant and Thrombin Products 2Health News:Haemacure and Angiotech Enter License, Distribution and Supply Agreements for Haemacure's All-Human Fibrin Sealant and Thrombin Products 3Health News:Haemacure and Angiotech Enter License, Distribution and Supply Agreements for Haemacure's All-Human Fibrin Sealant and Thrombin Products 4Health News:Duke University Health System Chooses SSI for Revenue Cycle Claims Management 2Health News:Duke University Health System Chooses SSI for Revenue Cycle Claims Management 3Health News:People who wear rose-colored glasses see more, University of Toronto study shows 2Health News:Effective over-the-counter prostate cancer test kit likely in next few years 2
(Date:9/30/2014)... Chindex International, Inc. ("Chindex" or ... the completion of its acquisition by Healthy Harmony Holdings, ... Healthy Harmony is an affiliate of TPG, Shanghai Fosun ... Lipson , the CEO of the Company. ... stockholders at a special meeting of stockholders held on ...
(Date:9/29/2014)... and PARIS , Sept. ... and Sanofi (EURONEXT: SAN and NYSE: SNY) today announced ... investigational therapy that blocks IL-4 and IL-13 signaling, met ... chronic sinusitis with nasal polyps (CSwNP) who did not ... suggest the potential of dupilumab for use in the ...
(Date:9/29/2014)... 29, 2014 Pharmacists have an important ... according to good clinical trials practices. The Hematology/Oncology ... Service Best Practice Standards, the first of its ... guidance for pharmacists and institutions that conduct clinical ... Standards emphasizes the critical role of the pharmacist ...
Breaking Medicine Technology:Chindex Completes Go-Private Transaction With Healthy Harmony Holdings, L.P. 2Chindex Completes Go-Private Transaction With Healthy Harmony Holdings, L.P. 3Chindex Completes Go-Private Transaction With Healthy Harmony Holdings, L.P. 4Chindex Completes Go-Private Transaction With Healthy Harmony Holdings, L.P. 5Regeneron and Sanofi Announce Positive Phase 2 Top-line Dupilumab Results in Patients with Chronic Sinusitis with Nasal Polyps 2Regeneron and Sanofi Announce Positive Phase 2 Top-line Dupilumab Results in Patients with Chronic Sinusitis with Nasal Polyps 3Regeneron and Sanofi Announce Positive Phase 2 Top-line Dupilumab Results in Patients with Chronic Sinusitis with Nasal Polyps 4Regeneron and Sanofi Announce Positive Phase 2 Top-line Dupilumab Results in Patients with Chronic Sinusitis with Nasal Polyps 5Regeneron and Sanofi Announce Positive Phase 2 Top-line Dupilumab Results in Patients with Chronic Sinusitis with Nasal Polyps 6Regeneron and Sanofi Announce Positive Phase 2 Top-line Dupilumab Results in Patients with Chronic Sinusitis with Nasal Polyps 7HOPA Introduces First Investigational Drug Service Best Practice Standards For Institutions And Infusion Clinics 2HOPA Introduces First Investigational Drug Service Best Practice Standards For Institutions And Infusion Clinics 3
...  BARRX Medical Inc., a leader in developing minimally invasive ... precancerous tissue from the gastrointestinal tract, announces today that ... by Covidien.  Covidien is a leading global provider of ... devices.  Covidien will acquire all of ...
... 2011 Medizone International (MZEI:OB MZEI:QB), a leading-edge ... and sterilization systems and SMTC Corporation (Nasdaq: SMTX, ... (EMS) provider, today jointly announce a new partnership ... . Medizone International CEO Edwin Marshall ...
Cached Medicine Technology:BARRX Medical, Inc. Announces Definitive Agreement to be Acquired by Covidien 2BARRX Medical, Inc. Announces Definitive Agreement to be Acquired by Covidien 3AsepticSure™ Production Agreement Awarded to SMTC 2AsepticSure™ Production Agreement Awarded to SMTC 3AsepticSure™ Production Agreement Awarded to SMTC 4
... 5 pages of various contrast levels showing 5 ... 9.5M. Contrast levels are 25%, 10%, 5%, 2.5% ... at several different distances. These two sets are ... different set of symbols to guard against ...
Directional `E' and `C' test....
9" X 14" translucent plastic may be used with illuminated test cabinet or as a wall chart 20/200 to 20/15....
... recording unit suitable for a wide range ... up to 16 input channels. Examples include ... unit is capable of recording at speeds ... second continuously to disk, and is compatible ...
Medicine Products: